Incidence of thyroid dysfunction in renal cell carcinoma (RCC) patients treated with pazopanib in prospective clinical trials.
P. Wolter
No relevant relationships to disclose
L. McCann
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
C. N. Sternberg
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
T. E. Hutson
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Pfizer; Wyeth
Honoraria - Bayer; GlaxoSmithKline; Pfizer; Wyeth
Research Funding - Bayer; GlaxoSmithKline; Pfizer; Wyeth
F. Mehmud
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
L. N. Pandite
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
P. Schoffski
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline